Status: current, Defined. Date: 31-Dec 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2178371000168118 | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2178381000168115 | Ondansetron ODT (Auro) 4 mg orally disintegrating tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Is a | Ondansetron ODT (Auro) | true | Inferred relationship | Some | ||
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Is a | ondansetron 4 mg orally disintegrating tablet | true | Inferred relationship | Some | ||
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | has manufactured dose form | orally disintegrating tablet | true | Inferred relationship | Some | ||
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | has unit of use | tablet | true | Inferred relationship | Some | 827911119 | |
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | has intended active ingredient | ondansetron | true | Inferred relationship | Some | 827911118 | |
| Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | has Australian BoSS | ondansetron | true | Inferred relationship | Some | 827911118 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 20 | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 10 | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 10, blister pack | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 20, blister pack | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 4 | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Ondansetron ODT (Auro) 4 mg orally disintegrating tablet, 4, blister pack | has TPUU | True | Ondansetron ODT (Auro) (ondansetron 4 mg) orally disintegrating tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR